Free Trial
OTCMKTS:BCYP

Big Cypress Acquisition (BCYP) Stock Price, News & Analysis

Big Cypress Acquisition logo
$8.44 -2.01 (-19.23%)
As of 10/22/2021

About Big Cypress Acquisition Stock (OTCMKTS:BCYP)

Key Stats

Today's Range
$8.21
$12.90
50-Day Range
$8.44
$8.44
52-Week Range
$8.21
$12.90
Volume
15.34 million shs
Average Volume
160,982 shs
Market Capitalization
$124.84 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BCYP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Big Cypress Acquisition and its competitors with MarketBeat's FREE daily newsletter.

BCYP Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
Solar Stock Losers in Sharp's Big U.S. Acquisition
Big Ass Fans
SAB Biotherapeutics Inc
See More Headlines

BCYP Stock Analysis - Frequently Asked Questions

Big Cypress Acquisition's stock was trading at $8.44 at the start of the year. Since then, BCYP shares have increased by 0.0% and is now trading at $8.44.

Big Cypress Acquisition Corp. (OTCMKTS:BCYP) released its quarterly earnings results on Tuesday, November, 11th. The technology company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01). The technology company earned $0.31 million during the quarter, compared to analysts' expectations of $0.21 million.

Shares of BCYP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Big Cypress Acquisition investors own include FuelCell Energy (FCEL), Onconova Therapeutics (ONTX), Co-Diagnostics (CODX), iBio (IBIO), Tonix Pharmaceuticals (TNXP), Vaxart (VXRT) and Adamis Pharmaceuticals (ADMP).

Company Calendar

Last Earnings
11/11/2014
Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
Personal Services
Current Symbol
OTCMKTS:BCYP
CIK
1399587
Fax
N/A
Employees
17
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.13
Quick Ratio
6.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
14,792,000
Free Float
N/A
Market Cap
$124.84 million
Optionable
Not Optionable
Beta
N/A
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:BCYP) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners